Reporting Bias in Clinical Trials: Progress Toward Transparency and Next Steps

The authors assess progress in addressing reporting bias in clinical trials noting that while regulatory requirements like ClinicalTrials.gov have improved transparency, studies still find that published literature overstates drug efficacy compared with FDA analyses.